SCHEMBL8269130

SCHEMBL8269130

O=C(Nc1ccc(Cl)cc1)[C@@H](O)CO

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.50
KMT2A Q03164 8/20 0.49
MEN1 O00255 7/20 0.49
GAA P10253 2/20 0.49
ATM Q13315 1/20 0.49
GPR55 Q9Y2T6 1/20 0.49
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.46
CNR1 P21554 3/20 0.46
TSHR P16473 2/20 0.46
POLB P06746 2/20 0.45
MAPT P10636 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HTT P42858 1/20 0.43
NLRP1 Q9C000 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10728276 0.84 ALDH1A1 (0.50) NPC1KMT2AMEN1GAAATM
SCHEMBL28100789 0.82 KMT2A (0.56) NPC1KMT2AMEN1GAAATM
SCHEMBL28548192 0.81 POLB (0.55) NPC1KMT2AMEN1GAAATM
SCHEMBL28100790 0.81 NPC1 (0.55) NPC1KMT2AMEN1GAAATM
SCHEMBL9614867 0.80 NPC1 (0.57) NPC1KMT2AMEN1GAAATM
SCHEMBL21835087 0.80 KMT2A (0.49) NPC1KMT2AMEN1GAAATM
SCHEMBL10431761 0.80 SPHK1 (0.56) NPC1KMT2AMEN1GAAATM
SCHEMBL11619407 0.79 TAS1R3 (0.39) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL17364296 0.78 PDE4A (0.46) NPC1KMT2AMEN1GAAATM
SCHEMBL2610069 0.78 KMT2A (0.54) NPC1KMT2AMEN1GAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006032342-A2 CARBONYL COMPOUND-CONTAINING DRUG AND THE USE THEREOF MERCK PATENT GMBH (DE) 2006-03-30 WO disclosed
WO-2004087646-A2 PYRROLIDINO-1,2-DICARBOXY-1-(PHENYLAMIDE)-2-(4-(3-OXO-MORPHOLINO-4-YL)-PHENYLAMIDE) DERIVATIVES AND RELATED COMPOUNDS FOR USE AS INHIBITORS OF COAGULATION FACTOR XA IN THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GMBH (DE) 2004-10-14 WO disclosed